Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Time to raise awareness regarding complications of androgen deprivation therapy.

× No keyword cloud information.

13 in total

Review 1. Androgen deprivation therapy-associated vasomotor symptoms.

Authors: Jason M Jones; Manish Kohli; Charles L Loprinzi
Journal: Asian J Androl Date: 2012-01-30 Impact factor: 3.285

Review 2. Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy.

Authors: Thomas W Storer; Renee Miciek; Thomas G Travison
Journal: Asian J Androl Date: 2012-02-27 Impact factor: 3.285

3. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.

Authors: E M Messing; J Manola; M Sarosdy; G Wilding; E D Crawford; D Trump
Journal: N Engl J Med Date: 1999-12-09 Impact factor: 91.245

4. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.

Authors: M Bolla; D Gonzalez; P Warde; J B Dubois; R O Mirimanoff; G Storme; J Bernier; A Kuten; C Sternberg; T Gil; L Collette; M Pierart
Journal: N Engl J Med Date: 1997-07-31 Impact factor: 91.245

5. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Authors: Rebecca Siegel; Elizabeth Ward; Otis Brawley; Ahmedin Jemal
Journal: CA Cancer J Clin Date: 2011-06-17 Impact factor: 508.702

Review 6. Quality of life issues in men undergoing androgen deprivation therapy: a review.

Authors: Rowan G Casey; Niall M Corcoran; S Larry Goldenberg
Journal: Asian J Androl Date: 2012-01-09 Impact factor: 3.285

Review 7. Hematological changes during androgen deprivation therapy.

Authors: Mathis Grossmann; Jeffrey D Zajac
Journal: Asian J Androl Date: 2012-01-09 Impact factor: 3.285

Review 8. Use of androgen deprivation therapy in prostate cancer: indications and prevalence.

Authors: Roisin M Connolly; Michael A Carducci; Emmanuel S Antonarakis
Journal: Asian J Androl Date: 2012-01-09 Impact factor: 3.285

Review 9. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma.

Authors: Vahakn B Shahinian; Yong-fang Kuo; Jean L Freeman; Eduardo Orihuela; James S Goodwin
Journal: Cancer Date: 2005-04-15 Impact factor: 6.860

Review 10. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis.

Authors: Sadeka Shahani; Milena Braga-Basaria; Shehzad Basaria
Journal: J Clin Endocrinol Metab Date: 2008-03-18 Impact factor: 5.958

1 in total

1. New study suggests patients with advanced prostate cancer on androgen deprivation therapy need more dialogue with health care provider, especially around cardiovascular risk.

Authors: Axel Merseburger; Anne Bro Falkenberg; Olga J Kornilova
Journal: World J Urol Date: 2018-09-22 Impact factor: 4.226

1 in total